United Therapeutics | UTHR - Ordinary Share Capital


United Therapeutics reported $42.38M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Amarin USD 20.81M 13K Dec/2025
Ardelyx USD 249.15M 2.17M Jun/2026
Baxter International USD 517M 549K Jun/2026
Bayer EUR 982.42M 0 Sep/2026
BioCryst Pharmaceuticals USD 255.26M 42.2M Jun/2026
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 193.68M 141K Sep/2026
Emergent BioSolutions USD 100K 0 Jun/2023
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 2.02B 2.05B Sep/2026
Halozyme Therapeutics USD 113.94M 106K Sep/2026
Insmed USD 218.28M 1.76M Jun/2026
Ionis Pharmaceuticals USD 166.41M 773K Sep/2026
J&J USD 2.41B 1.64M Jun/2026
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
Moderna USD 391M 2M Sep/2025
Omeros USD 611K 17K Dec/2023
Pfizer USD 5.7B 1000K Sep/2026
PTC Therapeutics USD 83.33M 445K Jun/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Sarepta Therapeutics USD 107.23M 1.61M Sep/2026
Teva Pharmaceutical Industries USD 1.17B 2M Sep/2026
United Therapeutics USD 42.38M 295K Sep/2026
Vertex Pharmaceuticals USD 253.5M 200K Sep/2026